Skip to main content
Commentaries
About Us
Contact Us
Media Appearances
Follow Us
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022
https://www.cdc.gov/mmwr/volumes/71/wr/mm7148e1.htm?s_cid=mm7148e1_w
Ruth Link-Gelles
Centers for Disease Control
November 22, 2022
